Pentacel Schedule options during DTaP allocations · a DTaP = Diphtheria, tetanus, and acellular...

a DTaP = Diphtheria, tetanus, and acellular pertussis.

Schedule options during DTaP allocationsUse these schedule options to help manage temporary allocations of Pentacel vaccine in your practice.

Before administering Pentacel vaccine, please see Important Safety Information on last page.

Range of recommended ages Certain high-risk groups All ages and certain high-risk groups

Vaccine Age Birth 1 month

2 months

4 months

6 months

9 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB

Diphtheria, Tetanus, Pertussis DTaP DTaP DTaP

Haemophilus influenzae type b Hib Hib Hib

Inactivated poliovirus IPV IPV

Rotavirus RV RV RV

Pneumococcal PCV PCV PCV

Influenza

Measles, Mumps, Rubella

Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

DTaP

IPV

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)

18 months

15 months

12 months

HepA series

Adapted from the recommended immunization schedule for persons aged 0 through 6 years—United States, 20121

IPV

DTaP

Hib


2 months

4 months

6 months

9 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB

Diphtheria, Tetanus, Pertussis DTaP DTaP DTaP

Haemophilus influenzae type b Hib Hib Hib


Rotavirus RV RV RV


Influenza


Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

DTaP

IPV

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)

18 months

15 months

12 months

HepA series

Impact of Pentacel vaccine on the immunization schedule1

Dose 1 Dose 2 Dose 3

vaccine

Dose 4

vaccine

a

Protection to grow on

Range of recommended ages

Certain high-risk groups

All ages and certain high-risk groups


Optimizing your supply of Pentacel vaccine and separately administered vaccines• Sanofi Pasteur offers the immunization options to assist you through the temporary allocation period


2 months

4 months

6 months

9 months

12 months

15 months

18 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB

Diphtheria, Tetanus, Pertussis DTaP

Haemophilus influenzae type b Hib

Inactivated poliovirus

Rotavirus RV RV RV


Influenza


Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)

vaccine vaccine vaccine

HepA series


2 months

4 months

6 months

9 months

12 months

15 months

18 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB



Inactivated poliovirus IPV

Rotavirus RV RV RV


Influenza


Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)


HepA series

Schedule option during temporary allocation of Pentacel vaccine1


DTaP

DTaP

IPV

IPV

Optimizing your supply of Pentacel vaccine and separately administered vaccines• Sanofi Pasteur offers the immunization options to assist you through the temporary allocation period






2 months

4 months

6 months

9 months

12 months

15 months

18 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB



Inactivated poliovirus

Rotavirus RV RV RV


Influenza


Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)

vaccinevaccine

HepA series

DTaP

Hib


2 months

4 months

6 months

9 months

12 months

15 months

18 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB

Diphtheria, Tetanus, PertussisHaemophilus influenzae type b


Rotavirus RV RV RV


Influenza


Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)


HepA series

DTaP

Hib

IPV

DTaP

DTaP

IPV



Optimizing your supply of Pentacel vaccine and separately administered vaccines• Sanofi Pasteur offers the immunization options to assist you through the

temporary allocation period






2 months

4 months

6 months

9 months

12 months

15 months

18 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB

Diphtheria, Tetanus, Pertussis DTaP DTaP

Haemophilus influenzae type b Hib Hib


Rotavirus RV RV RV


Influenza


Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)

vaccine

HepA series


2 months

4 months

6 months

9 months

12 months

15 months

18 months

19-23 months

2-3 years

4-6 years

Hepatitis B HepB

Diphtheria, Tetanus, Pertussis DTaP DTaP

Haemophilus influenzae type b Hib Hib


Rotavirus RV RV RV


Influenza


Varicella

Hepatitis A

Meningococcal

PPSV

MCV4

MMRMMR

VaricellaVaricella

Influenza (yearly)

HepB HepB

PCV

HepA (Dose 1)

vaccine

HepA series

vaccine

vaccine

DTaP

DTaP

IPV



Befo

re a

dmin

iste

ring

Pent

acel

vac

cine

, ple

ase

see

Impo

rtan

t Saf

ety

Info

rmat

ion

on la

st p

age.

Prac

tice:

Dat

e:

Vacc

ine

A

ge

Hep

atiti

s B

Dip

hthe

ria,

Tet

anus

, Pe

rtus

sis

Hae

mop

hilu

s inf

luen

zae

type

b

Inac

tivat

ed p

olio

viru

s

Rot

avir

us

Pneu

moc

occa

l

Influ

enza

Mea

sles

, Mum

ps, R

ubel

la

Vari

cella

Hep

atiti

s A

Men

ingo

cocc

al

Dur

ing

tem

pora

ry D

TaP

allo

catio

ns, u

se th

is b

lank

cha

rt to

cu

stom

ize

a te

mpo

rary

Pen

tace

l vac

cine

sche

dule

for y

our p

ract

ice.

Prot

ectio

n to

gro

w o

n

IMPORTAnT SAfeTy InfORMATIOn

InDIcATIOnPentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use as a 4-dose series in children 6 weeks through 4 years of age (prior tofifth birthday).

SAfeTy InfORMATIOnThe most common local and systemic adverse reactions to Pentacel vaccine include injection site redness, swelling, and tenderness; fever, fussiness, and crying. Other adverse reactions may occur. Known systemic hypersensitivity reaction to any component of Pentacel vaccine or a life-threatening reaction after previous administration of the vaccine or a vaccine containing the same substances are contraindications to vaccination.

The decision to give Pentacel vaccine should be based on the potential benefits and risks; if Guillain-Barré syndrome (GBS) has occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid; or if adverse events have occurred in temporal relation to receipt of pertussis-containing vaccine. Encephalopathy within 7 days of administration of a previousdose of a pertussis-containing vaccine or a progressive neurologic disorder is a contraindication. Vaccination with Pentacel vaccine may not protect all individuals.

Before administering Pentacel vaccine, please see accompanying full Prescribing Information.

For more information or assistance with schedule development, please contact your Sanofi Pasteur representative,

log onto VaccineShoppe.com®, or call 1-800-VACCINE (1-800-822-2463).

CPTb® Code: 90698 b CPT = Current Procedural Terminology is a registered trademark of the American Medical Association.

Pentacel vaccine is manufactured by Sanofi Pasteur Limited and Sanofi Pasteur SA and distributed by Sanofi Pasteur Inc.

Reference: 1. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years—United States, 2012. MMWR. 2012;61(5):1-4.

Sanofi PaSteur. Discovery Drive. Swiftwater, Pennsylvania 18370. www.sanofipasteur.us

MKt25210-1 © 2012 Sanofi Pasteur inc. 6/12 Printed in uSa

Pentacel Schedule options during DTaP allocations · a DTaP = Diphtheria, tetanus, and acellular...

Documents

Transcript of Pentacel Schedule options during DTaP allocations · a DTaP = Diphtheria, tetanus, and acellular...